Loading company…
Spot Biosystems develops extracellular vesicle technology for delivering gene therapies, with a focus on Duchenne muscular dystrophy.
Spot Biosystems is a biotechnology company based in San Francisco, US, developing gene delivery technology using extracellular vesicles. Its research focuses on improving delivery for genetic disorders, particularly Duchenne muscular dystrophy. In June 2026, the company raised USD 40 million in Series A funding from Advantech Capital and Tiger Jade Capital to advance its platform and treatment development.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in